| Members |
targetComponentId |
| Hemangiopericytoma, malignant |
Solitary fibrous tumor and hemangiopericytoma grade 3 (morphologic abnormality) |
| Hemarthrosis of other site, NEC |
Hemarthrosis |
| Hematoside (substance) |
GM3-ganglioside |
| Hemoglobin F-Calluna |
Haemoglobin F-Heather |
| Hemoglobin F-Iwata |
Haemoglobin F-Minoo |
| Hemoglobin F-Kuala Lumpur |
Hemoglobin F-Urumqi |
| Hemoglobin F-Siena |
Haemoglobin F-Carlton |
| Hemoglobin F-Yamaguchi |
Hemoglobin F-Marietta |
| Hemoglobin J-Kaohslung (substance) |
Haemoglobin J-Kaohsiung |
| Hemoglobin J-Nayanza |
Haemoglobin J-Nyanza |
| Hemoglobin S |
Haemoglobin S |
| Hemoglobin S disease |
Sickle cell-hemoglobin SS disease |
| Hemoglobin S disease with crisis |
Hemoglobin SS disease with crisis (disorder) |
| Hemoglobin S disease without crisis |
Hemoglobin SS disease without crisis (disorder) |
| Hemolysis (finding) |
Hemolysis |
| Hemolytic disease due to other isoimmunization, NEC |
Hemolytic disease of the newborn due to non-ABO, non-Rh isoimmunization |
| Hemolytic uremic syndrome |
Hemolytic uremic syndrome |
| Hemorrhagic fever with renal syndrome |
Hemorrhagic fever with renal syndrome (disorder) |
| Hemorrhagic nephroso-nephritis |
Hemorrhagic fever with renal syndrome (disorder) |
| Hemorrhoidectomy by injection |
Destruction of hemorrhoids by sclerotherapy |
| Hepadnaviridae |
Familia Hepadnaviridae |
| Heparin cofactor I (substance) |
Antithrombin III |
| Heparin sodium 100 unt/mL solution (product) |
Heparin (as porcine heparin sodium) 100 unit/mL solution for injection |
| Heparin sodium 1000iu/sodium chloride 0.9% infusion solution ampule |
Product containing only heparin in parenteral dose form (medicinal product form) |
| Heparin sodium 10u/mL injection solution ampule (product) |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
| Heparin sodium 10unt/mL solution (product) |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
| Heparin sodium in 0.9% sodium chloride 1000iu/500mL infusion (product) |
Product containing only heparin in parenteral dose form (medicinal product form) |
| Hepatectomy (procedure) |
Excision of liver (procedure) |
| Hepatic colic (finding) |
colique biliaire |
| Hepatitis (disorder) |
Inflammatory disease of liver |
| Hepatitis A immunoglobulin (medicinal product) |
Product containing only normal human immunoglobulin (medicinal product) |
| Orthohepadnavirus |
Orthohepadnavirus |
| Hepatitis B screening test |
Hepatitis B screening |
| Hepatitis B screening test |
Hepatitis B screening |
| Hepatitis B screening test |
Hepatitis B screening |
| Hepatitis non-A non-B |
hépatite virale |
| Hepatitis panel |
Hepatitis panel measurement (procedure) |
| Hepatocerebral encephalopathy |
encéphalopathie hépatique |
| Herbaspirillum rubrisualbicans |
Herbaspirillum rubrisubalbicans (organism) |
| Hereditary disease (disorder) |
maladie héréditaire |
| Hereditary endotheliopathy, retinopathy, nephropathy, stroke syndrome (disorder) |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| Hereditary methemoglobinemia, enzymatic type |
Autosomal recessive congenital methemoglobinemia (disorder) |
| HNSHA due to aldolase A deficiency |
Glycogen storage disease due to aldolase A deficiency (disorder) |
| HNSHA due to NADH-methemoglobin reductase deficiency |
Autosomal recessive congenital methemoglobinemia (disorder) |
| Hereditary progressive muscular dystrophy (disorder) |
Muscular dystrophy |
| Hereditary sensory-motor neuropathy, type V |
Hereditary motor and sensory neuropathy type 5 (disorder) |
| Hermansky-Pudlack syndrome |
Hermansky-Pudlak syndrome |
| Hermaphroditism (disorder) |
Ovotesticular disorder of sex development |
| Hermaphroditism |
Ovotesticular disorder of sex development |
| Heroin - non-pharmaceutical |
Diamorphine (substance) |
| Herpailurus yaguarondi (organism) |
Puma yagouaroundi (organism) |
| Herpes simplex with other specified complications |
Herpes simplex with complication |
| Herpes simplex with unspecified complications |
Herpes simplex with complication |
| Herpes zoster with other complications (disorder) |
zona avec complication |
| Herpes zoster with other nervous system complications |
Herpes zoster with nervous system complication |
| Herring - dietary |
Herring (substance) |
| Hetastarch 6% (product) |
Hetastarch 60 mg/mL solution for injection |
| Hetastarch 6g liquid (product) |
Hetastarch 60 mg/mL solution for injection |
| Hetastarch allergy |
Non-allergic hypersensitivity to hetastarch (finding) |
| Heteropagus |
Asymmetrical conjoined twins |
| Hexahydrophtalic anhydrid specific extract (product) |
Hexahydrophthalic anhydride (substance) |
| Hexamethylene diisocyanate specific extract (product) |
Hexamethylene diisocyanate (substance) |
| Hexosyltransferase |
Hexosyltransferase |
| High risk non proliferative diabetic retinopathy (disorder) |
rétinopathie diabétique non proliférante sévère |
| Risk of |
risque élevé de |
| Hind brain contusion with open intracranial wound, unspecified state of consciousness |
Contusion of hindbrain with open intracranial wound (disorder) |
| Hind brain contusion with open intracranial wound, with concussion, unspecified |
Contusion of hindbrain with open intracranial wound (disorder) |
| Hind brain contusion with open intracranial wound, with loss of consciousness of unspecified duration |
Contusion of hindbrain with open intracranial wound (disorder) |
| Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
| Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
| Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
| Hip enthesopathy NOS |
Enthesopathy of hip region |
| Hip enthesopathy, unspecified |
Enthesopathy of hip region |
| Hip fracture probability score using World Health Organization fracture risk assessment tool (observable entity) |
Hip fracture probability score using fracture risk assessment tool (observable entity) |
| Hip somatic dysfunction (finding) |
Somatic dysfunction of hip region (finding) |
| Hirundo fulva (organism) |
Petrochelidon fulva (organism) |
| Hirundo pyrrhonota (organism) |
Petrochelidon pyrrhonota (organism) |
| Histamine phosphate 275mcg/mL injection solution ampule (product) |
Histamine only product in parenteral dose form |
| Histiocytic proliferation - category (morphologic abnormality) |
Histiocytic proliferation (morphologic abnormality) |
| Histiocytoid hemangioma |
Epithelioid haemangioma |
| Histological grade |
Histologic grade (property) |
| Histological type |
Histologic type (property) (qualifier value) |
| H/O: angiotensin converting enzyme inhibitor allergy |
H/O: angiotensin converting enzyme inhibitor pseudoallergy |
| Hodgkin granuloma [obs] |
Hodgkin granuloma |
| Hodgkin lymphoma (category) |
Hodgkin lymphoma |
| Hodgkin sarcoma [obs] |
Hodgkin sarcoma (morphologic abnormality) |
| Hodgkin's disease, lymphocytic predominance (morphologic abnormality) |
Hodgkin lymphoma, lymphocyte-rich |
| Hodgkin's disease, lymphocytic predominance, diffuse (morphologic abnormality) |
Hodgkin lymphoma, lymphocyte-rich |
| Hodgkin's disease, nodular sclerosis, mixed cellularity (morphologic abnormality) |
Hodgkin lymphoma, nodular sclerosis, grade 1 |
| Hodgkin's paragranuloma |
Hodgkin lymphoma, nodular lymphocyte predominance (clinical) |
| Hodgkin's paragranuloma (morphologic abnormality) |
Hodgkin lymphoma, nodular lymphocyte predominance |
| Holborn sentence reading test |
Holborn Reading Scale (assessment scale) |
| Holmes Gang syndrome (disorder) |
X-linked intellectual disability hypotonic face syndrome |
| Homatropine hydrobromide 0.125% eye drops (product) |
Product containing precisely homatropine hydrobromide 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Homatropine hydrobromide 0.25% eye drops (product) |
Homatropine hydrobromide 2.5 mg/mL eye solution |
| Homatropine hydrobromide 0.5% eye drops |
Homatropine hydrobromide 5 mg/mL eye solution |
| Homatropine hydrobromide 5% eye drops (product) |
Homatropine hydrobromide 50 mg/mL eye solution |
| Homatropine hydrobromide 5%/mL solution (product) |
Homatropine hydrobromide 50 mg/mL eye solution |
| Home manager (housewife) |
Home manager |
| Home nebulizer used since last appointment (regime/therapy) |
Home nebulizer used since last encounter |
| Homodigital finger flap |
Flap (substance) |
FHIR